ATE328898T1 - Chemotaxis hemmendes protein von staphylococcus aureus (chips) und dessen verwendung - Google Patents

Chemotaxis hemmendes protein von staphylococcus aureus (chips) und dessen verwendung

Info

Publication number
ATE328898T1
ATE328898T1 AT99933284T AT99933284T ATE328898T1 AT E328898 T1 ATE328898 T1 AT E328898T1 AT 99933284 T AT99933284 T AT 99933284T AT 99933284 T AT99933284 T AT 99933284T AT E328898 T1 ATE328898 T1 AT E328898T1
Authority
AT
Austria
Prior art keywords
chips
staphylococcus aureus
inhibiting protein
chemotaxis inhibiting
treatment
Prior art date
Application number
AT99933284T
Other languages
English (en)
Inventor
Strijp Johannes Antonius G Van
Kessel Cornelis Petrus Mar Van
Original Assignee
Alligator Bioscience Ab Publ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alligator Bioscience Ab Publ filed Critical Alligator Bioscience Ab Publ
Application granted granted Critical
Publication of ATE328898T1 publication Critical patent/ATE328898T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99933284T 1998-07-10 1999-07-12 Chemotaxis hemmendes protein von staphylococcus aureus (chips) und dessen verwendung ATE328898T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL1009614 1998-07-10

Publications (1)

Publication Number Publication Date
ATE328898T1 true ATE328898T1 (de) 2006-06-15

Family

ID=19767471

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99933284T ATE328898T1 (de) 1998-07-10 1999-07-12 Chemotaxis hemmendes protein von staphylococcus aureus (chips) und dessen verwendung

Country Status (22)

Country Link
US (2) US20050143307A1 (de)
EP (1) EP1095059B1 (de)
JP (1) JP2002520336A (de)
KR (1) KR20010053290A (de)
CN (1) CN1309662A (de)
AT (1) ATE328898T1 (de)
AU (1) AU4935999A (de)
BG (1) BG105120A (de)
BR (1) BR9911944A (de)
CA (1) CA2333898A1 (de)
CY (1) CY1105343T1 (de)
DE (1) DE69931784T2 (de)
DK (1) DK1095059T3 (de)
ES (1) ES2270609T3 (de)
HU (1) HUP0102975A2 (de)
IL (1) IL140768A0 (de)
NO (1) NO20010140L (de)
NZ (1) NZ509051A (de)
PL (1) PL345452A1 (de)
PT (1) PT1095059E (de)
WO (1) WO2000002913A1 (de)
ZA (1) ZA200100092B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1309662A (zh) * 1998-07-10 2001-08-22 亚利制药有限公司 葡萄球菌属的趋化性抑制蛋白(chips)及其应用
EP1118663A1 (de) * 2000-01-07 2001-07-25 Universiteit Utrecht Nukleinsäuren kodierend für Chemotaxis-hemmende Polypeptide
US20020086292A1 (en) 2000-12-22 2002-07-04 Shigeaki Harayama Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules
WO2003006048A1 (en) * 2001-07-11 2003-01-23 Jari Pharmaceuticals B.V. Combination of chips (chemotaxis inhibiting protein from staphylococcus aureus)-based compounds
ES2360399T3 (es) * 2003-07-08 2011-06-03 Umc Utrecht Holding B.V. Uso terapéutico de lpi, un inhibidor de la vía de las lectinas de origen estafilocócico, en enfermedades inflamatorias.
EP1586583A3 (de) * 2004-04-16 2005-11-16 Alligator Bioscience AB (publ) Substanzen die der C5a Komplementrezeptor blockieren und deren Verwendung in der Therapie
US20090186111A1 (en) 2004-07-26 2009-07-23 Zeev Trainin Novel Bacteria and Pharmaceutically Active Products Obtained Therefrom
GB2432366B (en) * 2005-11-19 2007-11-21 Alligator Bioscience Ab A method for in vitro molecular evolution of protein function
GB0607798D0 (en) * 2006-04-20 2006-05-31 Alligator Bioscience Ab Novel polypeptides and use thereof
GB0905790D0 (en) 2009-04-03 2009-05-20 Alligator Bioscience Ab Novel polypeptides and use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772584A (en) * 1986-05-23 1988-09-20 Cleary Paul P Inhibitor of C5a-mediated chemotaxis
AU2509592A (en) * 1991-08-22 1993-03-16 Washington University Polynucleotide probes for salmonella
US5514555A (en) * 1993-03-12 1996-05-07 Center For Blood Research, Inc. Assays and therapeutic methods based on lymphocyte chemoattractants
US5514455A (en) * 1994-07-08 1996-05-07 Union Carbide Chemicals & Plastics Technology Corporation Film extruded from an in situ blend of ethylene copolymers
US5817476A (en) * 1995-06-07 1998-10-06 Genetics Institute, Inc. Polynucleotides encoding interleukin-1 receptor intracellular ligand proteins
US7153655B2 (en) * 1998-06-16 2006-12-26 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence
CN1309662A (zh) * 1998-07-10 2001-08-22 亚利制药有限公司 葡萄球菌属的趋化性抑制蛋白(chips)及其应用
JP3722194B2 (ja) * 1999-05-20 2005-11-30 セイコーエプソン株式会社 画像表示システム
EP1118663A1 (de) * 2000-01-07 2001-07-25 Universiteit Utrecht Nukleinsäuren kodierend für Chemotaxis-hemmende Polypeptide
US6958213B2 (en) * 2000-12-12 2005-10-25 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function
US20020086292A1 (en) * 2000-12-22 2002-07-04 Shigeaki Harayama Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules
DK1504098T4 (da) * 2002-05-17 2011-05-23 Alligator Bioscience Ab Fremgangsmåde til molekyulær udvikling in vitro af proteinfunktion

Also Published As

Publication number Publication date
DK1095059T3 (da) 2006-10-02
IL140768A0 (en) 2002-02-10
US20080242605A1 (en) 2008-10-02
EP1095059B1 (de) 2006-06-07
CN1309662A (zh) 2001-08-22
CY1105343T1 (el) 2010-03-03
ZA200100092B (en) 2001-07-23
BR9911944A (pt) 2001-09-25
AU4935999A (en) 2000-02-01
NZ509051A (en) 2003-01-31
WO2000002913A1 (en) 2000-01-20
DE69931784D1 (de) 2006-07-20
DE69931784T2 (de) 2007-06-14
KR20010053290A (ko) 2001-06-25
BG105120A (en) 2001-11-30
JP2002520336A (ja) 2002-07-09
HUP0102975A2 (hu) 2001-11-28
US20050143307A1 (en) 2005-06-30
NO20010140D0 (no) 2001-01-09
PT1095059E (pt) 2006-10-31
NO20010140L (no) 2001-03-01
ES2270609T3 (es) 2007-04-01
EP1095059A1 (de) 2001-05-02
PL345452A1 (en) 2001-12-17
WO2000002913B1 (en) 2000-03-30
CA2333898A1 (en) 2000-01-20

Similar Documents

Publication Publication Date Title
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
BRPI0307351B8 (pt) composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto
NO20051082L (no) Antimikrobielle kinoloner, deres sammensetninger og anvendelser
BRPI0414533A (pt) composto, composição farmacêutica, e, métodos para inibir um hsp90 e para tratar um indivìduo tendo um distúrbio mediado por hsp90
BR0013966A (pt) Compostos espiroeterocìclicos úteis como inibidores reversìveis de proteases de cisteìna
TR200200883T2 (tr) 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları
ATE233274T1 (de) Oxyiminopregnancarbolactone
ATE413388T1 (de) Muskarin antagonisten
ATE433963T1 (de) Fab-i inhibitoren
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
ATE328898T1 (de) Chemotaxis hemmendes protein von staphylococcus aureus (chips) und dessen verwendung
DE60129829D1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
TR200000907T2 (tr) Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.
MXPA04005809A (es) Inhibidores de proteinas quinasas.
ATE335739T1 (de) Cak inhibitoren und deren verwendungen
NO965097L (no) Nye elastaseinhibitorer
MXPA04004307A (es) Derivados de fenoxi-n-`4-(1,1-dioxoisotiazolidin-2-il)fenil-valeramida y otros compuestos como inhibidores del factor de coagulacion xa para el tratamiento de enfermedades tromboembolicas y tumores.
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
PT1232173E (pt) Derivados do acido fusidico
DK1051404T3 (da) Substituerede phenyluraciler med herbicid virkning
NO20053562L (no) Nye aminobenzofenonforbindelser
ATE286728T1 (de) Verwendung von homocysteinderivaten zur behandlung von bakteriellen infektionen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1095059

Country of ref document: EP

REN Ceased due to non-payment of the annual fee